---
layout: post
title: "Considerations for the Use of Human-and Animal-Derived Materials and Components in the Manufacture of Cell and Gene Therapy and Tissue-Engineered Medical Products; Draft Guidance for Industry; Availability"
date: 2026-02-05 19:09:23 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2024-09286
original_published: 2024-04-30 00:00:00 +0000
significance: 8.00
---

# Considerations for the Use of Human-and Animal-Derived Materials and Components in the Manufacture of Cell and Gene Therapy and Tissue-Engineered Medical Products; Draft Guidance for Industry; Availability

**Published:** February 05, 2026 19:09 UTC
**Source:** Federal Register
**Original Published:** April 30, 2024 00:00 UTC
**Document Number:** 2024-09286

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft document entitled "Considerations for the Use of Human- and Animal-Derived Materials and Components in the Manufacture of Cell and Gene Therapy and Tissue-Engineered Medical Products; Draft Guidance for Industry." The draft guidance document provides manufacturers of cellular and gene therapy (CGT) and tissue- engineered medical products (TEMPs) with recommendations regarding assuring the safety, quality, and identity of materials of human and animal origin used in the manufacture of these products. In addition, recommendations are provided regarding the chemistry, manufacturing, and control (CMC) information submitted in an investigational new drug application (IND) relating to the use of human- and animal-derived materials.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2024/04/30/2024-09286/considerations-for-the-use-of-human-and-animal-derived-materials-and-components-in-the-manufacture)
- API: https://www.federalregister.gov/api/v1/documents/2024-09286

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
